Literature DB >> 24952898

Identification of a high-risk group for low-dose aspirin-induced gastropathy by measuring serum pepsinogen in H. pylori-infected subjects.

K Iijima1, T Koike, N Ara, K Nakagawa, Y Kondo, K Uno, W Hatta, N Asano, A Imatani, T Shimosegawa.   

Abstract

BACKGROUND: We recently demonstrated in humans that the extent of low-dose aspirin (LDA)-induced gastropathy was directly related to the individual gastric acid secretion level. We also established reliable cutoff serum pepsinogen (PG) values to predict gastric acid secretion status. In this study, we investigated the clinical usefulness of measuring the serum pepsinogen values for identifying a high-risk group for gastric mucosal injury among chronic LDA users.
METHODS: One hundred long-term LDA users were enrolled in this analysis. Serum from each subject was subjected to determination of H. pylori status and measurement of pepsinogen values. According to our recent report, a PG I value ≥ 50 ng/mL was defined as estimated hyperchlorhydria in H. pylori-negative subjects, while a PG I/II ≥ 3.3 was defined as estimated hyperchlorhydria in H. pylori-positive subjects. The grade of gastric mucosal injury was assessed endoscopically, and multiple logistic regression analyses were used to estimate the risk.
RESULTS: Estimated hyperchlorhydria was a strong independent risk for intensive gastric mucosal injury with an OR (95% CI): 34.0 (4.5-259) and for gastric ulcer with an OR (95% CI): 10.2 (1.8-58.3) in H. pylori-positive subjects, while it was not a significant risk in H. pylori-negative subjects. The association persisted even after excluding those with conventional risks for LDA-gastropathy such as ulcer histories.
CONCLUSION: Using simple serum measurement of H. pylori antibody and pepsinogen concentrations, an extremely high-risk group for LDA-induced gastropathy could be extracted, and these patients should become a therapeutic target for prevention of LDA-induced gastropathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24952898     DOI: 10.1007/s00535-014-0976-5

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  36 in total

1.  Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Authors:  Peter Malfertheiner; Francis Megraud; Colm A O'Morain; John Atherton; Anthony T R Axon; Franco Bazzoli; Gian Franco Gensini; Javier P Gisbert; David Y Graham; Theodore Rokkas; Emad M El-Omar; Ernst J Kuipers
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

Review 2.  ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.

Authors:  Neena S Abraham; Mark A Hlatky; Elliott M Antman; Deepak L Bhatt; David J Bjorkman; Craig B Clark; Curt D Furberg; David A Johnson; Charles J Kahi; Loren Laine; Kenneth W Mahaffey; Eamonn M Quigley; James Scheiman; Laurence S Sperling; Gordon F Tomaselli
Journal:  Am J Gastroenterol       Date:  2010-12       Impact factor: 10.864

3.  Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori.

Authors:  M H Derakhshan; E El-Omar; K Oien; D Gillen; V Fyfe; J E Crabtree; K E L McColl
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

4.  Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence.

Authors:  I M Samloff; W M Liebman
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

5.  Association of gastric acid and mucus secretion level with low-dose aspirin-induced gastropathy.

Authors:  Katsunori Iijima; Nobuyuki Ara; Yasuhiko Abe; Tomoyuki Koike; Wataru Iwai; Toshimitsu Iwabuchi; Takafumi Ichikawa; Yayoi Kamata; Kazuhiko Ishihara; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2011-10-27       Impact factor: 7.527

Review 6.  Gastrointestinal lesions and complications of low-dose aspirin in the gastrointestinal tract.

Authors:  Carlos Sostres; Carla J Gargallo
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-04       Impact factor: 3.043

7.  Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level.

Authors:  Katsunori Iijima; Nobuyuki Ara; Yasuhiko Abe; Tomoyuki Koike; Toshimitsu Iwabuchi; Hirohiko Shinkai; Kaname Uno; Hiroyuki Endo; Naoki Asano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2012-05-02       Impact factor: 7.527

8.  Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population.

Authors:  M Asaka; T Kimura; M Kudo; H Takeda; S Mitani; T Miyazaki; K Miki; D Y Graham
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

9.  Reactive increase in gastric mucus secretion is an adaptive defense mechanism against low-dose aspirin-induced gastropathy.

Authors:  K Iijima; T Iwabuchi; N Ara; T Koike; H Shinkai; Y Kamata; T Ichikawa; K Ishihara; T Shimosegawa
Journal:  Dig Dis Sci       Date:  2013-05-07       Impact factor: 3.199

10.  Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.

Authors:  Kentaro Sugano; Yasushi Matsumoto; Tsukasa Itabashi; Sumihisa Abe; Nobuhiro Sakaki; Kiyoshi Ashida; Yuji Mizokami; Tsutomu Chiba; Shigeyuki Matsui; Tatsuya Kanto; Kazuyuki Shimada; Shinichiro Uchiyama; Naomi Uemura; Naoki Hiramatsu
Journal:  J Gastroenterol       Date:  2011-04-16       Impact factor: 7.527

View more
  4 in total

Review 1.  Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.

Authors:  Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

2.  Non-invasive method for the assessment of gastric acid secretion.

Authors:  Chiara Miraglia; Florenzo Moccia; Michele Russo; Serena Scida; Marilisa Franceschi; Pellegrino Crafa; Lorella Franzoni; Antonio Nouvenne; Tiziana Meschi; Gioacchino Leandro; Gian Luigi De' Angelis; Francesco Di Mario
Journal:  Acta Biomed       Date:  2018-12-17

3.  Efficacy of acotiamide on postprandial distress syndrome and epigastric pain syndrome depending on the estimated gastric acid secretion level.

Authors:  Toshiaki Suzuki; Reina Ohba; Ei Kataoka; Yui Kudo; Akira Zeniya; Daisuke Segawa; Keisuke Oikawa; Masaru Odashima; Taiji Saga; Tomoyuki Kuramitsu; Hideaki Sasahara; Kazuo Yoneyama; Takashi Tomita; Yosuke Shimodaira; Katsunori Iijima
Journal:  J Neurogastroenterol Motil       Date:  2022-01-30       Impact factor: 4.924

4.  Incidence of Infection among Subjects with Helicobacter pylori Seroconversion.

Authors:  Young Jung Kim; Sun-Young Lee; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park
Journal:  Clin Endosc       Date:  2021-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.